Simone Schoenwaelder: Women Are 25% More Likely to Have Their Stroke Misdiagnosed and Here’s Why
Simone Schoenwaelder, Head of Biology at ThromBio, shared on LinkedIn:
”Women are 25% more likely to have their stroke misdiagnosed… Here’s why.
A stroke warning every woman needs to hear.
In a report for the Herald Sun (‘Deadly stroke warning,’ Feb 18, 2026), journalist Robyn Riley spoke with Stroke Foundation CEO Dr Lisa Murphy about a confronting reality: more Australian women die from stroke than breast cancer — yet stroke receives far less awareness and research investment.
The article highlights two critical life stages where women face heightened risk:
Under 35 — pregnancy and birth, migraines with aura, and the contraceptive pill can all increase stroke risk
Post-menopause — the loss of oestrogen’s protective effect raises risk further, especially when combined with smoking or a history of high blood pressure or pre-eclampsia
Just as concerning, women are 25% more likely than men to be misdiagnosed in emergency departments, often because their symptoms present differently — think severe headache, confusion, or fatigue, rather than the more ‘textbook’ signs like facial drooping or slurred speech.
These atypical symptoms can be dismissed as stress or a migraine, and that delay can cost lives.
Greater public awareness, education of healthcare professionals, and recognition of non-traditional stroke symptoms are essential to ensure timely diagnosis and treatment.
Every minute matters; an estimated 1.9 million brain cells are lost with every minute a stroke goes untreated.
Recognise the signs – act fast – and call 000 – this can mean the difference between life and death—or between a full recovery and lifelong disability.
BE-FAST
- Balance loss,
- Eyes – sudden vision changes
- Face drooping
- Arm weakness
- Speech difficulty
Time to call emergency services immediately
The good news is that timely treatment can significantly improve outcomes for both women and men.
At ThromBio, we’re committed to developing the next generation of anti-clotting therapies to improve stroke treatment, save lives, and reduce disability.
Together, we can work towards a future where fewer people and families are affected by the devastating impact of stroke.
Full article: ‘Deadly stroke warning — Unique risk factors jeopardise women’s lives’ Robyn Riley, Herald Sun, 18 February 2026.”

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 10:32Ibrahim Gwarzo: Identifying Care Gaps and Emergency Pain Delays in Sickle Cell Disease at APHA 2026
-
Nov 15, 2026, 10:17Ify Osunkwo: How the Sickle Cell Community Can Influence FDA Drug Development Priorities
-
Nov 15, 2026, 10:11Ahmed Abdelsalam: Why Matching ABO and RhD Groups Does Not Guarantee Crossmatch Compatibility
-
Nov 15, 2026, 10:06Asma Khalil: New British Society for Haematology Guidance on Paediatric and Neonatal Transfusion
-
Nov 15, 2026, 09:41Girishkumar Modi: Navigating the 2026 Jehovah’s Witness Transfusion Policy Shift in Clinical Practice
-
Nov 15, 2026, 04:31Aakriti Gupta: Anticoagulation for Leaflet Thickening After TAVR
-
Nov 14, 2026, 23:57Jamie S. Y. Ho: Exploring the Mechanisms of Arterial Thrombosis and the Evolution of Antithrombotic Therapy
-
Nov 14, 2026, 23:53Jacopo Imberti: The Past, Present and Future of Arterial Thrombosis Research
-
Nov 14, 2026, 23:48Shrouk Ramadan: Joining the Editorial Review Board of Clinical and Applied Thrombosis and Hemostasis